Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40537

EEF1A2 Knockout A2780 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Ovary

  • Disease:

    Endometrioid carcinoma

CRISPR/Cas9-edited polyclonal knockout of EEF1A2 in A2780 ovarian cancer cells generates a heterogeneous loss-of-function pool for studying translation elongation and non-canonical functions. EEF1A2, regulated by mTORC1/S6K, MYC, and HIF1A, suppresses p53-mediated apoptosis and modulates actin dynamics. Its disruption enables dissection of mTOR/PI3K/AKT signaling and cisplatin sensitivity mechanisms in ovarian carcinoma. Suitable for Western blot, RT-qPCR, proliferation, apoptosis (caspase-3/7), migration, immunofluorescence, and polysome profiling assays to validate EEF1A2 loss and functional consequences. Contact Ascent Research for further information.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    A2780

    Sex of Donor

    Female

    Age

    Unknown

    Derived From Site

    In situ; Ovary

    Gene Name

    EEF1A2

    Gene Identifier

    NCBI Gene ID 1917

    Morphology

    Epithelial-like

    Growth Mode

    Adherent and suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EEF1A2 Knockout A2780 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population providing a heterogeneous pool with disrupted EEF1A2 function. The polyclonal format circumvents clonal selection artifacts, better reflecting biological variability of cancer populations and delivering a robust loss-of-function model.

The A2780 host cell line is an adherent epithelial line originally isolated from an untreated patient with ovarian carcinoma. It is widely employed as a model for high-grade serous ovarian cancer, recapitulating oncogenic signaling, apoptotic dysregulation, and chemotherapeutic drug sensitivity, particularly to cisplatin. Its well-characterized biology makes it an ideal background for EEF1A2 knockout studies.

EEF1A2 encodes a translation elongation factor that catalyzes GTP-dependent delivery of aminoacyl-tRNA to the ribosome, driving peptide chain elongation. Beyond protein synthesis, it inhibits p53-mediated apoptosis and organizes the actin cytoskeleton. Upstream, EEF1A2 is regulated by mTORC1/S6K signaling and transcriptionally activated by MYC and HIF1A. It forms complexes with the eEF1B components (EEF1B2, EEF1D, EEF1G) and interacts with actin, p53, and valyl-tRNA synthetase, thereby integrating growth and survival signals to coordinate translation, apoptosis suppression, and actin remodeling.

In A2780 cells, EEF1A2 overexpression contributes to enhanced translation, apoptotic resistance, and altered cell motility. Disruption of EEF1A2 in this polyclonal knockout enables dissection of mTOR/PI3K/AKT signaling networks and cisplatin sensitivity mechanisms. The model is particularly suited for investigating crosstalk between translational control and apoptosis in ovarian cancer, and the role of actin dynamics in metastatic potential.

This knockout pool is compatible with Western blotting and RT?qPCR for verifying EEF1A2 disruption, proliferation and caspase?3/7 activity assays for apoptosis assessment, cisplatin dose?response experiments to examine drug resistance, and migration/invasion assays to evaluate metastatic behavior. Immunofluorescence microscopy permits visualization of actin cytoskeletal reorganization, while polysome profiling reveals translation elongation defects. Researchers focused on ovarian cancer biology, translation regulation, or apoptosis will find this polyclonal knockout a powerful reagent for genetic perturbation studies. For additional information or customized cell engineering services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)